Results 31 to 40 of about 730,790 (291)

Hyponatremia – unfavourable prognostic factor in hepatic cirrhosis

Romanian Journal of Internal Medicine, 2016
Hyponatremia is defined by a level of Na in serum below or equal to 136 mEq/L while in hepatic cirrhosis it is classically considered as relevant only at a level of Na below 130 mEq/L.
Enescu Aurelia, Petrescu F., Mitruţ P., Pădureanu V., Petrescu Octavia Ileana, Albu Valeria Carmen, Moraru Andreea Larisa, Enescu Anca Ştefania   +7 more
doaj   +1 more source

HLF (hepatic leukemia factor) [PDF]

Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2011
Review on HLF (hepatic leukemia factor), with data on DNA, on the protein encoded, and where the gene is implicated.
openaire   +1 more source

Risk factors for hepatic encephalopathy in patients with liver cirrhosis: a retrospective study

Di-san junyi daxue xuebao, 2019
Objective To explore the risk factors associated with hepatic encephalopathy in patients with cirrhosis. Methods A total of 188 cirrhotic patients diagnosed with hepatic encephalopathy admitted in our hospital during June 2016 and June 2018 were enrolled
WANG Na, LI Juan, LI Xia, LIANG Luwen, WANG Xiaomei   +4 more
doaj   +1 more source

Hepatic fibrogenesis requires sympathetic neurotransmitters [PDF]

, 2004
Background and aims: Hepatic stellate cells (HSC) are activated by liver injury to become proliferative fibrogenic myofibroblasts. This process may be regulated by the sympathetic nervous system (SNS) but the mechanisms involved are unclear.
Diehl, AM, Huang, J, Li, Z, Lin, H, Moran, TH, Oben, JA, Roskams, T, Sinelli, N, Smedh, U, Thomas, SA, Torbenson, M, Yang, S   +11 more
core   +2 more sources

Association between severe hepatic steatosis examined by Fibroscan and the risk of high-risk colorectal neoplasia.

PLoS ONE, 2022
The prevalence of colorectal neoplasm in patients with non-alcoholic fatty liver disease has increased twice as high as that in the general population. FibroScan is a new modality for evaluating hepatic steatosis.
Kwang Woo Kim, Hyoun Woo Kang, Hosun Yoo, Yukyung Jun, Hyun Jung Lee, Jong Pil Im, Ji Won Kim, Joo Sung Kim, Seong-Joon Koh, Yong Jin Jung   +9 more
doaj   +1 more source

Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases [PDF]

, 2020
In the past ten years, our understanding of the importance of bile acids has expanded from fat absorption and glucose/lipid/energy homeostasis into potential therapeutic targets for amelioration of chronic cholestatic liver diseases.
Alpini, Gianfranco, Francis, Heather, Kennedy, Lindsey, Kundu, Debjyoti, Meadows, Vik   +4 more
core   +1 more source

GSK3 inhibitor ameliorates steatosis through the modulation of mitochondrial dysfunction in hepatocytes of obese patients

iScience, 2021
Summary: Obesity is an important risk factor and a potential treatment target for hepatic steatosis. The maladaptation of hepatic mitochondrial flexibility plays a key role in the hepatic steatosis.
Yaqiong Li, Yi Lin, Xueya Han, Weihong Li, Wenmao Yan, Yuejiao Ma, Xin Lu, Xiaowu Huang, Rixing Bai, Haiyan Zhang   +9 more
doaj   +1 more source

Chronic Activation of Hepatic Nrf2 Has No Major Effect on Fatty Acid and Glucose Metabolism in Adult Mice [PDF]

, 2016
The transcription factor NF-E2-related factor 2 (Nrf2) induces cytoprotective genes, but has also been linked to the regulation of hepatic energy metabolism. In order to assess the pharmacological potential of hepatic Nrf2 activation in metabolic disease,
Brachs, Maria, Brachs, Sebastian, Brunner, Bodo, Jahn-Hofmann, Kerstin, Margerie, Daniel, Polack, James, Ruetten, Hartmut, Schmoll, Dieter, Spranger, Joachim, Tang, Hui, Winkel, Angelika F.   +10 more
core   +3 more sources

Causal relationships between immune cells, inflammatory factors, serum metabolites, and hepatic cancer: A two-sample Mendelian randomization study

Heliyon
Background: Observational studies and clinical trials suggest associations between immune cells, inflammatory factors, serum metabolites, and hepatic cancer.
Hongyao Chen, Renyi Yang, Jingting Zhang, Jincheng Tang, Xiaopeng Yu, Wanshuang Zhou, Kexiong Li, Wei Peng, Puhua Zeng   +8 more
doaj   +1 more source

Characterization of distinct subpopulations of hepatic macrophages in HFD/obese mice. [PDF]

, 2014
The current dogma is that obesity-associated hepatic inflammation is due to increased Kupffer cell (KC) activation. However, recruited hepatic macrophages (RHMs) were recently shown to represent a sizable liver macrophage population in the context of ...
Bandyopadhyay, Gautam, Bogner-Strauss, Juliane G, Chi, Tyler J, Chung, Heekyung, Evans, Ronald M, Franck, Niclas, Hah, Nasun, Heinrichsdorff, Jan, Mayoral, Rafael, Morinaga, Hidetaka, Oh, Da Young, Olefsky, Jerrold M, Osborn, Olivia, Pessentheiner, Ariane R, Walenta, Evelyn   +14 more
core   +2 more sources